๐Ÿ‡บ๐Ÿ‡ธ US

EW revenue, net income and debt history (Edwards Lifesciences Corporation)

Quick answer

Edwards Lifesciences Corporation (EW) reported revenue of $6.07B and net income of $1.07B for the fiscal year ended 2025-12-31, up 11.5% from $5.44B the year before, per its 10-K filed with the SEC on 2026-02-25. Long-term debt stood at $598.3M.

โœ“ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$6.07B$1.07B$598.3M
2024 (FY ending 2024-12-31)$5.44B$4.17B$597.7M
2023 (FY ending 2023-12-31)$5.01B$1.40B$597.0M
2022 (FY ending 2022-12-31)$4.46B$1.52B$596.3M
2021 (FY ending 2021-12-31)$5.23B$1.50B$595.7M
2020 (FY ending 2020-12-31)$4.39Bโ€”$595.0M
2019 (FY ending 2019-12-31)$4.35Bโ€”$594.4M
2018 (FY ending 2018-12-31)$3.72Bโ€”$593.8M
2017 (FY ending 2017-12-31)$3.44Bโ€”$438.4M
2016 (FY ending 2016-12-31)$2.96Bโ€”$822.3M

Related

Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.

Related answers

Tools & live data

All Company Financials pages โ†’